Quarterly Activities/Appendix 4C Cash Flow Report
other announcement
Latest articles and price-sensitive announcements with AI sentiment classification.
other announcement
earnings announcement
Why Is Vitable Acquisition in Focus for Elixinol Wellness (ASX:EXL)? Kalkine
Highlights Elixinol Wellness has signed a binding agreement to acquire Australian supplement subscription platform Vitable in an all-scrip deal. The structure is majority-deferred and performance-based, designed to align the vendors' incentives with future results. The move follows the completed sale of Elixinol's American operations and a renewed focus on the Australian wellness market. Elixinol Wellness (ASX:EXL) has moved to reshape itself around the Australian health and wellness market, ...
other announcement
Is Elixinol Global (ASX:EXL) a Cannabis Stock to Watch as Global Growth Wobbles? Kalkine Media

Elixinol to acquire Vitable via all-scrip deal, adding subscription revenue and personalised tech; targets $27m revenue and $3m EBITDA by 2028; stock in focus.

Melbourne-based wellness company Elixinol Wellness (ASX: EXL) has entered a binding agreement to acquire Vitable, an Australian personalised supplement subscription platform, in an all-scrip deal with a headline equity value of $2.5 million and a potential additional $1 million performance kicker. The acquisition is designed to push the combine...
other announcement
other announcement
Elixinol Wellness Limited (ASX:EXL) has submitted an Appendix 3Y Change of Director's Interest Notice for CEO and Executive Director Natalie Butler, revealing the filing was made later than the deadline mandated by ASX Listing Rule 3.19A.2, due to an administrative error. Key Points The Appendix 3Y notice for director Natalie Butler was lodged late, missing the ASX Listing Rule 3.19A.2 deadline, caused by an administrative oversight. On 18 June 2026, Ms Butler sold 36,417 fully paid ordinary ...
director_dealing announcement
other announcement
other announcement
other announcement
other announcement
Highlights Elixinol Wellness confirmed it had received a binding offer covering the planned sale of its United States business The offer landed alongside half-year results the company described as a transformational period for the group The moves point toward a narrower, more focused hemp and plant-derived wellness business going forward Elixinol Wellness Limited (ASX:EXL) has confirmed receipt of a binding offer covering its United States business, releasing the news alongside half-year resu...
other announcement
other announcement
other announcement
other announcement
other announcement
Highlights Cultivation technology optimization reduces production costs Controlled environment agriculture enables consistent quality Sustainable cannabis production methods gain market adoption Cannabis producers increasingly adopt advanced cultivation technologies enabling higher yields, improved product consistency, and reduced environmental impact. The broader [ASX 200] remains an important benchmark for Australian market sentiment. Elixinol Global (ASX:EXL) operates within this evolving ...
Highlights Clinical research expands therapeutic understanding of cannabinoids Pharmaceutical development focuses on standardized cannabinoid formulations Research collaborations strengthen evidence base for medical applications Research into cannabis and cannabinoid therapeutics has accelerated dramatically as regulatory frameworks permitted scientific investigation into previously restricted compounds. The broader [ASX 200] remains an important benchmark for Australian market sentiment. Aca...
other announcement
Elixinol Wellness (ASX: EXL): Can This Wellness Stock Stage a Turnaround? Kalkine
Elixinol Wellness (ASX:EXL): Premium Wellness Portfolio Strategy Gives a Fresh Investor Angle Kalkine
other announcement
other announcement
other announcement
other announcement
other announcement
other announcement